You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR FINASTERIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FINASTERIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002651 ↗	SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer	Completed	Cancer and Leukemia Group B	Phase 3	1995-05-01	RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 ↗	SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer	Completed	Eastern Cooperative Oncology Group	Phase 3	1995-05-01	RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 ↗	SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer	Completed	European Organisation for Research and Treatment of Cancer - EORTC	Phase 3	1995-05-01	RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 ↗	SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer	Completed	National Cancer Institute (NCI)	Phase 3	1995-05-01	RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FINASTERIDE

Condition Name

Chart
Table

Condition Name for FINASTERIDE
Intervention	Trials
Benign Prostatic Hyperplasia	12
Androgenetic Alopecia	10
Healthy	10
Prostate Cancer	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FINASTERIDE
Intervention	Trials
Prostatic Hyperplasia	24
Hyperplasia	22
Alopecia	18
Alopecia Areata	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FINASTERIDE

Trials by Country

Map
Table

Trials by Country for FINASTERIDE
Location	Trials
United States	124
Canada	19
Korea, Republic of	8
Mexico	6
Egypt	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FINASTERIDE
Location	Trials
Florida	10
Texas	10
California	8
Illinois	7
New York	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FINASTERIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FINASTERIDE
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	17
Phase 2/Phase 3	1
[disabled in preview]	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FINASTERIDE
Clinical Trial Phase	Trials
Completed	50
Recruiting	7
Terminated	6
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FINASTERIDE

Sponsor Name

Chart
Table

Sponsor Name for FINASTERIDE
Sponsor	Trials
GlaxoSmithKline	5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	4
National Institutes of Health (NIH)	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FINASTERIDE
Sponsor	Trials
Other	61
Industry	47
NIH	19
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.